AKER CHRISTOPHER RAY (Sr. VP & General Counsel) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/17/2024ACC: 0001209191-24-001771
Officer· Sr. VP & General Counsel
Since Jan 2019
+81.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
81.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.25K
Price / share
—
Trade value
—
% of position
263.2%
1/12/2024
4.27K→15.52K
Total
Net shares
+11.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2024 | A · Award | +11.25K | — | — | 263.2% | 4.27K | 15.52K |
| Total | +11.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
70K shares
Shares
+70K
Strike price
1.30
Held after
70K
Exercisable
—
1/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock70K shares | 1/12/2024 | A · Award | +70K | 1.30 | — | 70K |